Arterialization of peripheral venous blood in sickle cell disease

被引:0
|
作者
Nahavandi, M [1 ]
Millis, RM [1 ]
Tavakkoli, F [1 ]
Wyche, MQ [1 ]
Perlin, E [1 ]
Winter, WP [1 ]
Castro, O [1 ]
机构
[1] Howard Univ, Coll Med, Dept Anesthesiol, Washington, DC 20060 USA
关键词
sickle cell disease; vasocclusion; oxygen saturation; arteriovenous shunting;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arterialization of the venous blood is thought to be indicative of cutaneous shunting, and occurs in patients with sickle cell disease (SCD) during vaso-occlusive crisis (VOC). We performed the present study to quantify the amount of shunting that occurs in sickle cell patients presenting at the Howard University Sickle Cell Center, Washington, D.C., as outpatients and for hospitalizations associated with sickle cell crisis. Peripheral venous blood was drawn anaerobically into heparinized syringes from 9 normal control subjects (NC), 24 outpatients (steady-state group), and 14 inpatients during crisis (VOC group). Spectrophotometric measurements were made for the following species of hemoglobin (Hb): oxy-Hb (O(2)Hb), reduced Hb (RHb), carboxy-Hb (COHb), and met-Hb (MHb). In addition, fetal hemoglobin (HbF) was measured by high-pressure liquid chromatography (HPLC), The O(2)Hb saturations of the steady state group were not significantly different than those of the NC group (55+/-4% vs. 40+/-6%). However, the O(2)Hb saturations of the VOC group were 73+/-3%, and this value was found to be significantly greater than those of both the steady-state and the NC groups (p<0.05). Reduced hemoglobin saturations were inversely related to the O(2)Hb values, as expected. Compared to the NC group, the steady-state, and VOC groups had greater dyshemoglobin (COHb and MHb) levels (p<0.05). These findings suggest that the percentages of venous O(2)Hb and dyshemoglobins may be increased in sickle cell disease even in the absence of VOC. Therefore, the venous O(2)Hb saturation may be a useful biochemical marker for the arteriovenous shunting and hemodynamic adaptations associated with sickle cell disease.
引用
收藏
页码:320 / 326
页数:7
相关论文
共 50 条
  • [21] Peripheral neuropathy and sickle cell disease.
    Ballas, SK
    Reyes, PF
    BLOOD, 1997, 90 (10) : 2786 - 2786
  • [22] Blood transfusion in sickle cell disease
    Davies, SC
    RobertsHarewood, M
    BLOOD REVIEWS, 1997, 11 (02) : 57 - 71
  • [23] Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients
    Ionescu, Filip
    Anusim, Nwabundo
    Zimmer, Markie
    Jaiyesimi, Ishmael
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (03) : 282 - 288
  • [24] BLOOD TRANSFUSION IN SICKLE CELL DISEASE
    Marouf, Rajaa
    HEMOGLOBIN, 2011, 35 (5-6) : 495 - 502
  • [25] Hybrid superficial venous arterialization and endovascular deep venous arterialization
    Montero-Baker, Miguel
    Sommerset, Jill
    Miranda, Jorge A.
    JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES, 2023, 9 (03):
  • [26] Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor
    Uchida, Naoya
    Leonard, Alexis
    Stroncek, David
    Panch, Sandhya R.
    West, Kamille
    Molloy, Eoghan
    Hughes, Thomas E.
    Hauffe, Sara
    Taylor, Tiffani
    Fitzhugh, Courtney
    Hankins, Jane S.
    Wilson, Megan
    Sharma, Akshay
    Tsai, Shengdar Q.
    Weiss, Mitchell J.
    Hsieh, Matthew
    Tisdale, John F.
    HAEMATOLOGICA, 2020, 105 (10) : E497 - E501
  • [27] Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease
    Saraf, Santosh L.
    Oh, Annie L.
    Patel, Pritesh R.
    Sweiss, Karen
    Koshy, Matthew
    Campbell-Lee, Sally
    Gowhari, Michel
    Jain, Shivi
    Peace, David
    Quigley, John G.
    Khan, Irum
    Molokie, Robert E.
    Mahmud, Nadim
    Gordeuk, Victor R.
    Rondelli, Damiano
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1759 - 1765
  • [28] Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor
    Leonard, Alexis
    Uchida, Naoya
    Stroncek, David F.
    Panch, Sandhya R.
    West, Kamille
    Molloy, Eoghan George
    Hughes, Tom
    Hauffe, Sara
    Taylor, Tiffani
    Fitzhugh, Courtney D.
    Hankins, Jane S.
    Wilson, Megan
    Sharma, Akshay
    Tsai, Shengdar Q.
    Weiss, Mitchell J.
    Hsieh, Matthew
    Tisdale, John F.
    BLOOD, 2019, 134
  • [29] Sirolimus associated pneumonitis after nonmyeloablative peripheral blood stem cell transplant for sickle cell disease
    Hsieh, Matthew M.
    Link, M. Beth
    Tisdale, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 256 - 257
  • [30] Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease
    Saraf, Santosh L.
    Patel, Pritesh
    Sweiss, Karen
    Annie, Oh
    Koshy, Matthew
    Campbell-lee, Sally
    Gowhari, Michel
    Jain, Shivi
    Peace, David
    Quigley, John G.
    Khan, Irum
    Molokie, Robert E.
    Mahmud, Nadim
    Gordeuk, Victor R.
    Rondelli, Damiano
    BLOOD, 2017, 130